Supernus Pharmaceuticals
SUPN
#4344
Rank
A$3.95 B
Marketcap
A$68.06
Share price
0.59%
Change (1 day)
33.71%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: A$3.95 Billion

As of July 2026 Supernus Pharmaceuticals has a market cap of A$3.95 Billion. This makes Supernus Pharmaceuticals the world's 4344th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.95 B-10.52%
2025A$4.41 B33.75%
2024A$3.30 B42.23%
2023A$2.32 B-18.1%
2022A$2.83 B32.47%
2021A$2.13 B23.65%
2020A$1.72 B-2.8%
2019A$1.77 B-27.86%
2018A$2.46 B-5.72%
2017A$2.61 B50.79%
2016A$1.73 B91.94%
2015A$0.90 B107.44%
2014A$0.43 B28.95%
2013A$0.33 B59.97%
2012A$0.21 B

End of Day market cap according to different sources

On Jul 20th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

A$3.92 Billion
by Nasdaq info icon info icon
A$3.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$860.27 B 21,677.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$247.74 B 6,171.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.487 T 37,567.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$177.17 B 4,385.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
A$2.14 B-45.81%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$37.98 B 861.65%๐Ÿ‡บ๐Ÿ‡ธ USA